Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$112M |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$79.6M |
| 3 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$41.3M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$24.6M |
| 5 |
Global Payments
GPN
|
+$23M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$104M |
| 2 |
IHS
IHS INC CL-A COM STK
IHS
|
+$30.4M |
| 3 |
Pfizer
PFE
|
+$25.8M |
| 4 |
H&R Block
HRB
|
+$23.6M |
| 5 |
Quest Diagnostics
DGX
|
+$23.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.51% |
| 2 | Healthcare | 11.03% |
| 3 | Industrials | 10.52% |
| 4 | Consumer Discretionary | 7.22% |
| 5 | Financials | 4.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $584M | 22.38% |
2,985,700
+1,699,500
| +132% | +$323M |
|
|
2
Apple
AAPL
$4.51T
| $122M | 4.67% |
+5,248,200
| New | +$112M |
|
|
3
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$809B
| $116M | 4.45% |
594,100
-592,300
| -50% | -$113M |
|
|
4
iShares MSCI Emerging Markets ETF
EEM
$30.7B
| $96.8M | 3.71% |
2,240,000
+1,876,000
| +515% | +$79.6M |
|
5
CALL
American International
AIG
$39.8B
| $85.4M | 3.27% |
+1,564,400
| New | +$82.8M |
|
6
PUT
iShares Russell 2000 ETF
IWM
$81.9B
| $59.4M | 2.28% |
+500,000
| New | +$56.8M |
|
|
7
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33.1B
| $41.6M | 1.59% |
+348,721
| New | +$41.3M |
|
8
Workday
WDAY
$49.4B
| $40.3M | 1.54% |
448,250
-139,100
| -24% | -$10.9M |
|
|
9
State Street SPDR S&P Regional Banking ETF
KRE
$4.5B
| $25.2M | 0.97% |
+625,000
| New | +$24.6M |
|
|
MNK
10
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
| $24.7M | 0.95% |
308,900
-51,200
| -14% | -$3.71M |
|
|
11
Global Payments
GPN
$24.7B
| $24.3M | 0.93% |
+667,200
| New | +$23M |
|
12
Meta Platforms (Facebook)
META
$1.4T
| $24.1M | 0.92% |
357,703
+335,944
| +1,544% | +$20.7M |
|
13
Illinois Tool Works
ITW
$80.4B
| $23.6M | 0.9% |
269,000
-65,398
| -20% | -$5.62M |
|
|
AGN
14
DELISTED
Allergan plc
AGN
| $22.6M | 0.87% |
101,500
+48,300
| +91% | +$10M |
|
15
Eli Lilly
LLY
$1.12T
| $22.4M | 0.86% |
360,300
+355,600
| +7,566% | +$21.2M |
|
16
Perrigo
PRGO
$1.98B
| $21.9M | 0.84% |
150,000
+148,200
| +8,233% | +$21M |
|
17
Mastercard
MA
$509B
| $20.7M | 0.79% |
282,009
+277,301
| +5,890% | +$20.6M |
|
18
Paychex
PAYX
$44.3B
| $20.6M | 0.79% |
494,600
-246,816
| -33% | -$10.1M |
|
19
Lennox International
LII
$13.9B
| $20.4M | 0.78% |
227,483
+135,283
| +147% | +$11.8M |
|
20
Danaher
DHR
$154B
| $19.7M | 0.75% |
371,958
+335,888
| +931% | +$17.3M |
|
21
Union Pacific
UNP
$183B
| $19.6M | 0.75% |
196,190
-3,810
| -2% | -$369K |
|
22
Bath & Body Works
BBWI
$3.92B
| $19.1M | 0.73% |
402,025
+154,625
| +63% | +$7.08M |
|
23
Mohawk Industries
MHK
$9.23B
| $17.7M | 0.68% |
128,157
-21,497
| -14% | -$2.91M |
|
24
Visa
V
$693B
| $16.9M | 0.65% |
321,348
-415,068
| -56% | -$21.7M |
|
|
CFN
25
DELISTED
CAREFUSION CORPORATION
CFN
| $16M | 0.61% |
361,300
+343,008
| +1,875% | +$14.2M |
|
Similar funds
Paul Tudor Jones's Q2 2014 Portfolio in Review
As of Q2 2014, Paul Tudor Jones held 1,510 positions worth $2.61B, up 11% from $2.36B the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Paul Tudor Jones deployed $161M of net new capital in Q2 2014, opening 336 new positions and adding to 390 existing holdings. Its largest new stake was Apple: 5,248,200 shares worth $122M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 9.3% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Pfizer, an estimated $25.8M trimmed.
- Paul Tudor Jones's largest Q2 2014 buy was Apple: 5,248,200 shares worth $122M.
- Paul Tudor Jones added most to iShares MSCI Emerging Markets ETF in Q2 2014, an estimated $79.6M increase.
- Paul Tudor Jones's biggest Q2 2014 reduction was Pfizer, cutting an estimated $25.8M.
- Paul Tudor Jones fully exited iShares iBoxx $ High Yield Corporate Bond ETF in Q2 2014, selling an estimated $104M.
- Paul Tudor Jones's ten largest holdings make up 46% of its $2.61B portfolio in Q2 2014.
- Paul Tudor Jones opened 336 new positions and closed 367 in Q2 2014.
- Paul Tudor Jones's portfolio value rose 11% quarter-over-quarter to $2.61B.
Based on Tudor Investment Corp's 13F filing for Q2 2014, filed 14 Aug 2014.